Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barni

Showing results (71-80 of 369) with videos related to

Pageof 37
Sort By:
Annals of the New York Academy of Sciences|September 30, 1995
Modulation of tumor necrosis factor-alpha (TNF-alpha) toxicity by the pineal hormone melatonin (MLT) in metastatic solid tumor patientsR Braczkowski, B Zubelewicz, W Romanowski, et al.
Acta Anatomica|January 1, 1981
Effects of isoprenaline treatment on the rat liver parenchyma. Ultrastructural investigationsS Barni, M Speziali, P De Piceis Polver, et al.
Minerva Pediatrica|July 10, 1999
[Urinary tract ultrasonography in newborns with late oligohydramnios]S Barni, M Pezzati, G Danesi, et al.
Acta Histochemica|January 1, 1978
Glycogen changes in the liver cells of young rats following isoprenaline treatment. (Histochemical and ultrastructural investigations)P De Piceis Polver, S Barni, C Fenoglio, et al.
Tumori|November 1, 1995
Endocrine effects of granulocyte colony-stimulating factor in cancer patientsF Rovelli, S Barni, G Tancini, et al.
Tumori|June 30, 1988
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancerP Lissoni, S Barni, S Crispino, et al.
Journal of Endocrinological Investigation|February 1, 1990
A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemiaP Lissoni, E Mainini, C Mazzi, et al.
Tumori|December 31, 1993
Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance statusP Lissoni, F Brivio, A Ardizzoia, et al.
The International Journal of Biological Markers|October 1, 1988
Soluble interleukin-2 receptor levels in Hodgkin's disease: preliminary considerations about their prognostic significanceP Lissoni, S Barni, F Rovelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Bisphosphonates and metastatic bone diseaseS Barni, M Mandalà, M Cazzaniga, et al.
Pageof 37

Showing results (71-80 of 369) with videos related to

Sort By:
Pageof 37
Annals of the New York Academy of Sciences|September 30, 1995
Modulation of tumor necrosis factor-alpha (TNF-alpha) toxicity by the pineal hormone melatonin (MLT) in metastatic solid tumor patientsR Braczkowski, B Zubelewicz, W Romanowski, et al.
Acta Anatomica|January 1, 1981
Effects of isoprenaline treatment on the rat liver parenchyma. Ultrastructural investigationsS Barni, M Speziali, P De Piceis Polver, et al.
Minerva Pediatrica|July 10, 1999
[Urinary tract ultrasonography in newborns with late oligohydramnios]S Barni, M Pezzati, G Danesi, et al.
Acta Histochemica|January 1, 1978
Glycogen changes in the liver cells of young rats following isoprenaline treatment. (Histochemical and ultrastructural investigations)P De Piceis Polver, S Barni, C Fenoglio, et al.
Tumori|November 1, 1995
Endocrine effects of granulocyte colony-stimulating factor in cancer patientsF Rovelli, S Barni, G Tancini, et al.
Tumori|June 30, 1988
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancerP Lissoni, S Barni, S Crispino, et al.
Journal of Endocrinological Investigation|February 1, 1990
A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemiaP Lissoni, E Mainini, C Mazzi, et al.
Tumori|December 31, 1993
Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance statusP Lissoni, F Brivio, A Ardizzoia, et al.
The International Journal of Biological Markers|October 1, 1988
Soluble interleukin-2 receptor levels in Hodgkin's disease: preliminary considerations about their prognostic significanceP Lissoni, S Barni, F Rovelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
Bisphosphonates and metastatic bone diseaseS Barni, M Mandalà, M Cazzaniga, et al.
Pageof 37